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PLACEBO EFFECTS OF CAFFEINE ON MAXIMAL VOLUNTARY CONCENTRIC FORCE 31 
OF THE KNEE FLEXORS & EXTENSORS  32 
 33 
ABSTRACT 34 
 35 
Introduction: We examined the placebo effect of caffeine and the combined effect of caffeine and 36 
caffeine expectancy on maximal voluntary strength. Methods: Fourteen men completed 4 randomized 37 
single-blind experimental trials: 1) Told caffeine, given caffeine (5mg.kg) (CC); 2) Told caffeine, 38 
given placebo (CP); 3) Told placebo, given placebo (PP); 4) Told placebo, given caffeine (PC). 39 
Maximal voluntary concentric force and fatigue resistance of the knee flexors and extensors was 40 
measured using isokinetic dynamometry. Results: A significant and equal improvement in peak 41 
concentric force was found in the CC and PC trials. Despite participants believing caffeine would 42 
evoke a performance benefit, there was no effect of CP. Conclusion: Caffeine caused an improvement 43 
in some aspects of muscle strength, however there was no additional effect of expectancy. Performance 44 
was poorer in participants who believed caffeine would have the largest benefit, which highlights a link 45 
between expected ergogenicity, motivation, and personality characteristics.  46 
 47 
KEY WORDS: Strength, Isokinetic Dynamometry, Ergogenic Aids, Deception, Caffeine, Placebo.  48 
 49 
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INTRODUCTION 61 
 62 
The popularity of caffeine as an ergogenic aid is supported by a growing body of literature that 63 
demonstrates its performance-enhancing effects across a range of sporting activities and exercise 64 
intensities (See reviews 1-4) Recently, a relatively small number of studies have shown that the 65 
expectation of caffeine is sufficient to elicit a performance-enhancing response, when in fact a placebo 66 
was consumed (5-9). Such findings highlight an important additional mechanism underpinning the 67 
performance-enhancing effect of caffeine. To date, placebo effects of caffeine have only been 68 
examined using a limited range of exercise modes and intensities. Consequently, there is a need for 69 
additional studies on this topic to better elucidate the extent to which the expectancy of performance-70 
enhancement of caffeine or the actual effect of caffeine ingestion contribute to improved exercise 71 
performance. 72 
 73 
The placebo effect is a favorable outcome arising purely from the belief that one has received a 74 
beneficial treatment (10). Although not a particularly new concept, the placebo effect has been 75 
demonstrated to be a powerful tool for manipulating physiological, psychological, and behavioral 76 
variables, (11) and its positive effects in medicine are widely appreciated (12). A recent meta-analysis 77 
considered that, although only a relatively small number of studies have examined the placebo effect 78 
on sports performance, different forms of placebo may evoke substantial performance enhancement (13). 79 
 80 
Likely due to its widespread use and well documented effects as an ergogenic aid (1), a relatively small 81 
number of research papers  have examined the placebo effect on sports performance in relation to 82 
caffeine (see review 14). Beedie et al. (5) reported that a caffeine placebo caused increased mean power 83 
during 10km time trial performance in well trained cyclists, which was greatest when participants 84 
believed they had ingested a higher concentration of caffeine. This was later supported by Foad, 85 
Beedie, and Coleman (6), who demonstrated that caffeine, and the perception of consuming caffeine, 86 
caused small improvements in 40km cycling performance. Work by Foad, Beedie, and Coleman (6) and 87 
Duncan (9) represent only a small number of research papers that have used a double dissociation 88 
protocol to assess the placebo effect of caffeine. This design allows the assessment of independent 89 
effects of placebo, the pharmacological effects of the treatment, and their interaction, and is considered 90 
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to be a more robust measure of placebo effects (12). Duncan (9) demonstrated a significant increase in 91 
mean and peak Wingate power when participants consumed placebo that they believed to be caffeine, 92 
and a further improvement was seen when participants consumed caffeine that they perceived to be 93 
caffeine. This indicates that the expectation of caffeine could be an ecologically valid mechanism for 94 
the caffeine effect in sport and exercise, but this has still to be measured in relation to maximal muscle 95 
strength.   96 
   97 
Using a more traditional protocol of deception, Pollo et al. (7) demonstrated that when compared to a 98 
non-ergogenic placebo, there was a significant increase in the mean work of the quadriceps muscle 99 
during a 60% 1RM (Rep Max) protocol to voluntary exhaustion in participants who believed they had 100 
consumed a high dose of caffeine. Interestingly, the placebo-induced increase in work was greater 101 
when a conditioning procedure, consisting of a pre-test lifting protocol which was surreptitiously 102 
lowered to 45% 1RM, was used to reinforce the placebo effect. This result was later confirmed by 103 
Duncan et al. (8) who reported a significant increase in the number of knee extensions until failure, 104 
using a similar 60% 1RM protocol, when participants perceived they had consumed caffeine. These 105 
results further demonstrated that the increase in performance was associated with a reduction in Rating 106 
of Perceived Exertion (RPE), indicating that a caffeine-induced reduction in the perception of effort 107 
may mechanistically contribute to the demonstrated improvement in performance. 108 
 109 
The majority of studies of the effect of caffeine on exercise performance have implemented a placebo 110 
controlled double blind experimental protocol (15-18), and although this is considered the most robust 111 
way of examining the effect of caffeine on performance, such products are purchased by consumers 112 
with the expectancy of an improvement in performance which may pose additional benefits to the 113 
typical cognitive and physiological changes evoked by caffeine consumption (19, 20). Beedie (21) 114 
considered that such placebo controlled trials may mask the true caffeine effect. The pharmacologically 115 
and mechanistically inert placebo may evoke psychological responses, as participants expect to 116 
consume caffeine at some point during the experiment.  117 
  118 
The study we report here looks to build on previous work by investigating the placebo effect of 119 
caffeine on maximal voluntary peak and average concentric force of the knee flexor and extensor 120 
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muscles at two different angular velocities. A double deception protocol, as in Beadie and Foad (12), 121 
was implemented to assess the placebo effect of caffeine and the effect of caffeine expectancy on 122 
maximal voluntary force production of skeletal muscle. Furthermore this study investigated the placebo 123 
effect of caffeine and the effect of caffeine expectancy on the ability to produce maximal voluntary 124 
concentric force over 40 repeated contractions. Gains in maximal muscle strength and the ability to 125 
sustain this improvement over time would be desirable across a range of sport and exercise activities. 126 
In addition, improved maximal voluntary force production may translate to improved performance 127 
across a range of contractile intensities, as skeletal muscle will theoretically be able to produce the 128 
desired force at lower intensities with a smaller number of recruited fibers.  129 
 130 
 131 
 132 
 133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
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METHODS 151 
 152 
Participants 153 
 154 
Following ethical approval from the host institute (Coventry University) and obtaining informed 155 
consent, 14 apparently healthy men (mean ± SE = age 21 ± 0.7 years; height 177 ± 1.3 cm; body mass 156 
76 ± 2.2 kg) agreed to take part in the study. Participants were told that they would be taking part in a 157 
study examining the repeatability of the effects of caffeine on maximal muscular strength and 158 
fatigability of maximal voluntary force production. Over the duration of the experiment, 3 participants 159 
had to withdraw from the study due to injuries that were not associated with the experimental 160 
procedure. The participants who completed the tests were naive to strength training and habitually 161 
consumed caffeine, but were not heavy caffeine users (91.8 ± 16.1 mg/day). Caffeine intake was 162 
measured using a 24 hour recall questionnaire (22). 163 
 164 
All experiments took place at the same time of day to avoid circadian variation (23), and participants 165 
were asked to abstain from high intensity activity and caffeine 48 hours prior to each visit to the 166 
laboratory. Participants visited the laboratory at Coventry University on 5 occasions, and each visit was 167 
separated by at least 48 hours.   168 
 169 
Familiarization   170 
 171 
In the first visit heavy clothing and shoes were removed, and measures of height (cm) and mass (kg) 172 
were taken to the nearest cm and 100g, using a stadiometer (SECA Instruments Ltd., Germany) and 173 
electronic weighing scales (SECA Instruments Ltd., Germany). Participants were then familiarized 174 
with isokinetic dynamometry (Kin-com 125 AP, Chattanooga, Tennessee, USA) and the experimental 175 
procedure. 176 
 177 
Similar to the study by Green et al. (24), participants completed a 5 minute warm-up on a cycle 178 
ergometer (Monark 857E, United States) at 70 rpm (unloaded cradle), followed by 5 minutes of static 179 
and dynamic stretches of the muscle groups involved (gastrocnemius, soleus, hamstrings, and 180 
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quadriceps). Participants then used the warm-up feature on the isokinetic dynamometer and were 181 
instructed to perform concentric extension and flexion of the knee at a moderate intensity.  The 182 
isokinetic dynamometer was set up in accordance with the manufacturer’s instructions, and the lateral 183 
femoral epicondyle and lateral malleolus were used as the anatomical reference points for the knee and 184 
ankle (25). Dynamometer head and seat position for each individual were stored and recalled for each 185 
subsequent visit. Maximal voluntary peak and average concentric force during knee flexion and 186 
extension of the dominant leg were reordered through a range of motion of 800-10°, at velocities of 300 187 
and 120°/second. Each velocity was separated by 60 seconds recovery.  Maximal voluntary force was 188 
achieved with 2-3 attempts, which is common for this type of testing (25). Following a 10 minute rest 189 
period, participants then performed a bout of 40 repetitions of knee extension and flexion of the 190 
dominant leg at a velocity of 120°/second in the same manner as previously described. Peak and 191 
average force for knee extension and flexion were recorded for each repetition. 192 
 193 
Experimental Procedure 194 
 195 
Prior to participation, and before each trial where participants believed caffeine would be consumed, a 196 
brief synopsis of the performance-enhancing effects of caffeine on measures of maximal strength was 197 
provided verbally. Participants completed 4 experimental trials in a counterbalanced, randomized 198 
format using a single blind, double-disassociation procedure. This has previously been used in studies 199 
of the placebo effect on sports performance (12). The experimental conditions were as follows: 1) Told 200 
caffeine, given caffeine (CC); 2) Told caffeine, given placebo (CP); 3) Told placebo, given placebo 201 
(PP); 4) Told placebo, given caffeine (PC). Caffeine drinks contained 5 mg/kg body mass of caffeine 202 
(Myprotein, UK) diluted in 4 ml/kg water and 1ml/kg double concentrate sugar free orange cordial 203 
(Sainsbury’s, UK), and were artificially sweetened with 3mg/kg sucralose (Myprotein, UK). Five 204 
mg/kg represents a moderate caffeine dose and is regularly used in studies examining its ergogenic 205 
effect on sports performance (15, 17, 18). Placebo drinks were prepared in the same way with the absence 206 
of caffeine. Following a 10 minute rest period and resting measures of Heart Rate (HR; measured in 207 
bpm) and Blood Lactate (BLa; measured in mmol/l), drinks were presented to participants in an opaque 208 
sports bottle and were asked to consume the contents within 5 minutes. HR was assessed using heart 209 
rate telemetry (Polar Electro, Finland), and BLa was measured from a finger prick sample using a 210 
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Lactate Pro (Akray, Japan). The participants then rested for 45 minutes, and resting HR and BLa 211 
measures were taken. Following this, the participants completed the warm up procedure as previously 212 
described. The strength assessments began 60 minutes post-ingestion in line with previous evidence 213 
that demonstrates maximal blood plasma concentration of caffeine occurs 1 hour post-consumption 214 
(Graham et al. 2001). The strength assessments were carried out using the isokinetic dynamometer in 215 
the same manner as previously described. Further HR and BLa measures were taken prior to the 40 216 
repeated contractions, on completion of the exercise protocol, and 5 minutes post-recovery. Pain 217 
perception was recorded immediately after assessment of maximal voluntary force at both 300 and 218 
120°/second and again immediately after the 40 contractions using the pain perception scale (26).. 219 
 220 
Perception of Caffeine as a Performance Enhancer 221 
 222 
Prior to the experimental protocol, participants were asked to rate the extent to which they believed 223 
caffeine would affect their performance on a scale from -5, a very negative effect, to +5, a very positive 224 
effect. Following the experimental trials, but prior to debriefing, participants were asked to rate their 225 
belief about caffeine for a second time to see if the experimental protocol affected the participants’ 226 
perception of caffeine as a performance enhancer. At no point during any of the experimental trials did 227 
participants correctly identify the test substance consumed or the true nature of the study.  228 
 229 
Statistical Method 230 
 231 
Normality and homogeneity of variance were tested using Shapiro–Wilk and Mauchly tests 232 
respectively. A series of Treatment (4) X Speed (2) repeated measures ANOVAs were used to examine 233 
statistical differences in peak and average concentric force of the knee flexors and extensors, and the 234 
perception of pain following the measurement of contractile force.  Similarly, Treatment (4) x Rep (40) 235 
repeated measures ANOVAs were used to assess potential treatment-induced changes in peak and 236 
average force produced during the repeated 40 contraction protocol. A further series of Treatment (4) x 237 
Time (4) repeated measures ANOVAs were used to assess changes in HR and BLa at rest and during 238 
exercise. Finally, single factor repeated measures ANOVA was used to examine main effects for 239 
perception of pain. Pairwise comparisons were used for treatment where appropriate.   Partial eta 240 
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squared (η2) was used as a measure of effect size. Partial η2 is commonly used in analysis of variance 241 
and provides a measure of the variance in the dependant variable attributable to the factor in question 242 
(27).  243 
 244 
A paired t-test was used to examine if the perception of caffeine as a performance enhancer changed 245 
significantly post-completion of the experimental trials. Following the debriefing session, no 246 
participant confessed to have predicted the true nature of the experiment. Considering that the 247 
perception of a performance-enhancing benefit underpins the nature of the placebo effect, it was 248 
considered important to examine these results on an individual level. The percentage change in 249 
maximal peak and average force from the PP trial to the CP trial was calculated and a series of Pearson 250 
correlations were used to examine the relationship between maximal voluntary strength and the score 251 
given on the post-experimental caffeine perception questionnaire. 252 
 253 
Data are presented as mean ± SE. Statistical analysis was performed using SPSS 22.0 (Chicago, IL, 254 
USA). Statistical significance was set at a level of P<0.05. 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
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RESULTS 271 
 272 
Maximal Peak & Average Force 273 
 274 
There was no significant treatment*speed interaction for peak and average knee flexor and extensor 275 
force in any of the statistical tests (Fig 1; ANOVA F<1.4; P>0.27; Pη2<0.12 in each case). Peak and 276 
average concentric force production of the knee flexors and extensors was significantly reduced at 277 
1200/s compared to 300/s (Figure 1 A-D; ANOVA F>20; P<0.001; Pη2>0.66 in all cases).  278 
 279 
Peak concentric force of the knee extensors was significantly affected by treatment (Figure 1 A; 280 
ANOVA F=8.3; P<0.01; Pη2=0.454). Peak force produced during the PC and CC trial was 281 
significantly greater than the PP trial (by 12.8% and 15.8% respectively at 30°/second and 6.8% and 282 
11.2% respectively at 120°/second; Figure 1 A, pairwise P<0.05 in both cases), but the given increase 283 
in force was not different between PC and CC trials (Figure 1 A, t-test P>0.6 for both speeds). Average 284 
force was also significantly affected by treatment (Figure 1 B, ANOVA F=5.8; P=0.003; Pη2=0.37), 285 
with that produced in the CC trial being significantly greater than PP (by 18.0% and 14.4% at 30° and 286 
120°/second; Figure 1 B; pairwise P=0.02). Peak and average force of the hamstrings was not 287 
significantly affected by treatment (Figure 1 C,D; F<0.17; P>0.74; Pη2<0.04 in both cases). 288 
 289 
There was no significant effect of treatment, speed, or interaction of these factors for measurements of 290 
pain perception (Table 1; ANOVA F<2.4; P>0.08; Pη2<0.2 in each case).  291 
 292 
** Figure 1 and Table 1 around here ** 293 
 294 
Repeated Maximal Voluntary Contractions 295 
 296 
Both peak and average force of the knee extensors and flexors was significantly reduced over the 297 
course of the 40 repeated contraction protocol (Figures 2&3; F>51.5; P<0.001; Pη2>0.83 in all cases), 298 
however there was no significant effect of treatment (Figures 2&3; F<1.05; P>0.38; Pη2<0.095 in all 299 
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cases). Furthermore there was no significant treatment*rep interaction in all cases (Figures 2&3; F<1.3; 300 
P>0.06; Pη2<0.12). 301 
** Figure 2 & 3 around here ** 302 
 303 
Although HR and BLa were both significantly affected by time (Table 2; ANOVA F>36.7; p<0.001; 304 
Pη2>0.78 in each case), no effects of treatment were found (Table 2: ANOVA F<0.3; p>0.83; 305 
Pη2<0.03 in each case). There was no significant Treatment*Time interaction (Table 2; ANOVA 306 
F<1.3; p>0.27; Pη2<0.11). Furthermore the perception of pain was not significantly affected by 307 
treatment (Table 1; ANOVA F=1.01; p=3.99; Pη2=0.092). 308 
 309 
** Table 2 around here ** 310 
 311 
The Effect of Caffeine Perception on Performance. 312 
 313 
Prior to participating in the experimental protocol, all participants believed that the consumption of 314 
caffeine would result in improved exercise performance (mean +3.09 ± 0.435), which had not 315 
significantly changed at the end of the protocol (mean +3.18 ± 0.423, paired samples t-test t=-1.00 316 
P=0.341). Table 3 demonstrates that when participants considered caffeine to be more beneficial to 317 
performance, there was a negative association with performance in the CP trial, although this was only 318 
significant in peak force of the knee extensors measured at 120°/second. 319 
 320 
** Table 3 around here ** 321 
 322 
 323 
 324 
 325 
 326 
 327 
 328 
 329 
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DISCUSSION 330 
 331 
Regardless of expectation, caffeine treatment caused a significant increase in peak concentric force of 332 
the knee extensors. There were no caffeine or caffeine placebo effects on maximal peak and average 333 
force of the knee flexors, or the ability of the knee flexors and extensors to maintain peak and average 334 
force over 40 repeated contractions. These findings add further weight to the evidence which suggests 335 
that caffeine may be used as an ergogenic aid in events requiring acute maximal strength, but they 336 
demonstrate that the perception of caffeine is not sufficient to elicit a performance-enhancing effect in 337 
this mode of exercise. As such these results provide an important insight into the relationship between 338 
physiological and psychological effects of caffeine as a performance enhancer for skeletal muscle 339 
contractility  340 
 341 
Placebo Effect of Caffeine 342 
 343 
The findings contradict the previous evidence that a caffeine placebo can cause a significant increase in 344 
exercise performance (6-9, 21). More specifically, these results directly contradict the findings of Pollo et 345 
al. (7) and Duncan (8), who reported a caffeine placebo caused significant improvements in measures of 346 
muscle work and repetitions until failure using a 60% 1RM protocol. Initially this may indicate that the 347 
mechanism by which a placebo elicits its effect is in some way limited during activities requiring 348 
sustained maximal effort. Although few studies have examined a placebo effect on measures of 349 
maximal strength, there is some evidence that a performance benefit can be elicited following acute 350 
and chronic supplementation of different placebos, where an increased performance is expected (28, 29).  351 
 352 
Beyond the work of Kalasountas et al. (29) there is a distinct lack of evidence investigative the effect of 353 
an acute placebo on maximal strength. Furthermore, a number of methodological discrepancies should 354 
be considered when comparing the present findings to the positive effect demonstrated in previous 355 
studies examining placebo effects on measures of muscular strength (7, 8, 28, 29). Most notably a number 356 
of studies use submaximal measures of strength, and the use of free weights is mechanically different 357 
for assessing strength at a fixed velocity. Additionally, differences occur in the nature and duration of 358 
the placebo and the ability of the participants, cumulatively making comparisons between these studies 359 
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problematic. Furthermore an experimental effect is more likely in open-ended tests of muscle strength 360 
(as in 7, 9) compared to the fixed-end test we used(30).   361 
 362 
The effectiveness of the placebo to elicit a performance-enhancing effect is attributed to the perception 363 
that one believes that a performance-enhancing benefit will occur (10).  Geers et al. (31) concluded that 364 
personality and situational variables interact to determine the response to a placebo, and that perceived 365 
optimism or pessimism will result in a positive or negative placebo response. When the results are 366 
explored on an individual level, all participants believed that caffeine would cause a performance-367 
enhancing effect, however this did not result in a significant change in maximal voluntary strength 368 
when the CP trial was compared to the PP trial. Interestingly, these results infer that when the benefit is 369 
perceived to be small, the placebo effect is greater, and when the benefit is perceived to be large, the 370 
placebo effect is smaller. This may appear to contradict the underpinning theory that supports the 371 
placebo effect, and although the rationale for this is not clear, we speculate that this finding may relate 372 
to individual motivation to complete the task. For example, the belief that the consumed substance will 373 
cause a significant improvement in maximal voluntary strength may result in reduced effort, as a high 374 
performance is expected.  In light of these findings, more should be made of the reinforcement 375 
approach introduced by Pollo et al. (7), as having a physical demonstration of the effectiveness of the 376 
treatment, albeit false, may more strongly manipulate the power of perception. 377 
 378 
Mechanistically, the placebo effect can in part be attributed to its effect on modulating pain perception 379 
(5, 9). In support of this, some previous studies have demonstrated positive effects of a caffeine placebo 380 
on RPE in relation to improvements in exercise performance that may underpin this as a mechanism for 381 
the placebo effect in sporting activities. Contradictory findings in our study demonstrate that the 382 
perception of pain is unchanged when a perceived performance-enhancing placebo is administered. 383 
This may not be particularly surprising, since there was no effect of placebo on exercise performance, 384 
but it may leave one to speculate that the lack of effect may be attributed to a lack of change in this 385 
measure.   386 
 387 
The Effect of Caffeine on Maximal Strength 388 
 389 
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The only significant effect of treatment found in this study was a caffeine-induced improvement in 390 
peak and average concentric force of the knee flexors. Interestingly, even when the participants 391 
believed they were completing a placebo trial, caffeine still caused a significant and equal increase in 392 
maximal concentric force of the quadriceps. This result in particular supports the value of caffeine in 393 
improving maximal voluntary force; however this effect cannot be maintained during repeated 394 
contractions. Furthermore, the results demonstrate that this effect is not uniform across all skeletal 395 
muscle. 396 
 397 
Unlike the research investigating the performance enhancing effect of caffeine on endurance exercise, 398 
the body of work exploring the ergogenic effect of caffeine on measures of muscle strength are much 399 
more equivocal, with evidence of both substantial strength gains (32-34) and no effect (35-37). The nature of 400 
these discrepancies has largely been attributed to methodological differences, including participant 401 
training status, assessment methods, muscle groups tested, and concentration of caffeine. Although it is 402 
generally considered that caffeine elicits greater effects in trained athletes (4), our study further 403 
demonstrates the value for untrained participants.     404 
 405 
Although not statistically significant, Timmins and Saunders (38) suggested that the benefit of caffeine 406 
on muscle strength may relate to muscle size. This may partially be why there was no effect of caffeine 407 
on the knee flexors, although Timmins and Saunders (38) demonstrated performance-enhancing benefits 408 
in muscles much smaller than the hamstrings. Furthermore, studies using isolated muscle have 409 
demonstrated fiber type specific effects on contractility following direct caffeine treatment (39) which 410 
may have also caused the varying effect. It may also be that the action of producing maximal voluntary 411 
concentric force of the hamstrings is a more irregular muscle action, and hence the repeatability of 412 
maximal force between trials may influence the results.    413 
There is a distinct lack of studies of the effects of caffeine on the ability to sustain force over repeated 414 
contractions. Although our findings infer that there is no additional caffeine benefit, caffeine-induced 415 
increases in maximal voluntary force production may translate into improved resistance to fatigue at 416 
submaximal exercise intensities, as theoretically the muscle will be able to produce greater work with a 417 
smaller number of recruited  fibers. 418 
 419 
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The hydrophobic nature of caffeine allows it to pass across all biological membranes (19), and as such, 420 
caffeine may elicit a performance-enhancing effect by a number of mechanisms. Most commonly 421 
reported, and aligned to the mode of exercise used in this study, is the action of caffeine as a central 422 
nervous system stimulant. Caffeine has been demonstrated to act as a central adenosine receptor 423 
antagonist, particularly on A1 and A2a receptors, promoting an elevated release of neurotransmitters 424 
(40-42). The subsequent reduction in the adenosine-induced suppression of dopamine release (43, 44) is 425 
believed to contribute to the commonly reported increased alertness and arousal (20). In addition, a 426 
recent review (39) has indicated that caffeine may work directly to increase the force-producing capacity 427 
of skeletal muscle. A reduction in pain perception has also been attributed to the performance gains 428 
demonstrated in previous studies of caffeine-induced improvements in muscle strength (3, 45, 46). 429 
However, our findings add to the growing body of evidence indicating that modulation of pain 430 
perception is not a primary mechanism causing performance-enhancement in muscle strength (47, 48). 431 
 432 
An additional aim of this work was to examine whether caffeine expectancy caused a further 433 
enhancement in performance. This is considered a more ecologically valid method of testing the 434 
caffeine effect on sports performance, as caffeine-containing products are purchased with the intention 435 
of seeking an improvement in exercise performance. As no significant difference was found in the 436 
improvement in the concentric action of knee flexors and extensors between the CC and PC trials, or in 437 
any of the placebo trials, we believe that caffeine expectancy does not further augment the 438 
physiological and psychological benefits provided by caffeine alone.    439 
 440 
Conclusion 441 
 442 
In contrast to previous studies using different modes of exercise, the present work demonstrates that a 443 
caffeine placebo fails to elicit a performance enhancing effect on measures of maximal voluntary 444 
strength. These findings are particularly interesting, since all participants believed that caffeine 445 
treatment would lead to a substantial improvement in performance. Uniquely, we found that 446 
participants who perceived the performance effect to be greater demonstrated the smallest change in 447 
performance in the exercise trial, which potentially highlights a link between expected ergogenicity, 448 
motivation to perform high intensity fatiguing exercise, and personality characteristics. These findings 449 
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further demonstrate that caffeine treatment caused significant improvement in some aspects of acute 450 
maximal voluntary strength. When caffeine treatment and caffeine expectancy were combined, there 451 
was no additional benefit. These findings highlight the importance of the mechanistic changes caused 452 
by caffeine to evoke an improvement in performance, however when a perceived treatment-induced 453 
enhancement of performance is expected, this does not necessarily translate to improved exercise 454 
performance. Future research examining the placebo effect should look to further investigate the 455 
relationship between the magnitude of the perceived benefit and exercise performance. 456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
 479 
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ABBREVIATIONS 480 
 481 
η2  Partial eta squared 
° Degrees 
ANOVA Analysis of Variance 
BLa Blood Lactate 
CC Told Caffeine, Given Caffeine 
Cm Centimetres 
CP Told Caffeine, Given Placebo 
Fig Figure 
HR Heart Rate 
Km Kilometres 
Mg Milligrams 
ml Millilitre 
mmol/l milllimole per litre 
PC Told Placebo, Given Caffeine 
PP Told Placebo, Given Placebo 
RM Rep Max 
RPE Rating of Perceived Exertion 
SE Standard Error of the Mean 
SPSS Statistical Package for the Social Science 
 482 
 483 
 484 
 485 
 486 
 487 
 488 
 489 
 490 
 491 
 492 
 493 
 494 
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FIGURES 669 
Figure 1. The placebo effect of caffeine on peak and average maximal voluntary concentric contractile 670 
force of the knee extensor (A & B) and flexor muscles (C & D) at 300 and 120 0/s [Data are represented 671 
as mean ± SE; n=11 in each case; matching symbols indicate statistically significant differences] 672 
 673 
Figure 2. The placebo effect of caffeine on peak (A) and average (B) concentric force of the knee 674 
extensors over 40 repeated maximal voluntary contractions. [Data represented as mean ± SE; n=11 in 675 
each case] 676 
 677 
Figure 3. The placebo effect of caffeine on peak (A) and average (B) concentric force of the knee 678 
flexors over 40 repeated maximal voluntary contractions. [Data represented as mean ± SE; n=11 in 679 
each case] 680 
 681 
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TABLES 699 
[Data represented as mean ± SE; n=11 in each case] 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
 714 
 715 
 716 
 717 
 718 
 719 
 720 
Table 1. The placebo effect of caffeine on pain perception following maximal voluntary isokinetic force 
of the knee flexors and extensors measured at 30, 120, and 40 repeated contractions 
 30°/s 120°/s Post 40 
PP 2.5±0.6 2.1±0.6 6±0.6 
CP 2.3±0.4 1.7±0.5 7±0.6 
PC 2.1±0.5 2.5±0.6 6±0.6 
CC 1.8±0.4 2.5±0.5 6±0.6 
23 
 
 
 
Table 2. The placebo effect of caffeine on resting and post exercise measures of HR and BLa 
 Pre-Ing Post-Ing Pre 40 reps Post 40 reps 5 min post 
 HR (BPM) 
PP 71±5 75±6 89±5 147±7 101±6 
CP 69±4 73±4 85±5 151±7 105±6 
PC 71±4 70±4 90±6 155±7 103±6 
CC 69±4 73±5 83±5 156±7 105±4 
 Bla (mmol/l) 
PP 2.3±0.4 2.0±0.2 2.8±0.8 6.4±1.2 6.0±0.9 
CP 2.9±0.5 1.8±0.1 2.5±0.4 5.5±0.8 5.7±0.8 
PC 1.9±0.3 2.0±0.2 2.5±0.3 6.8±1.1 6.2±2.1 
CC 1.9±0.2 3.1±0.8 2.8±0.4 5.6±0.5 7.3±1.2 
[Data represented as mean ± SE; n=11 in each case] 721 
 722 
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 727 
 728 
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 732 
 733 
 734 
 735 
 736 
 737 
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Table 3. Individual percentage difference in maximal voluntary muscle strength 
between PP and CP trial correlated against the perceived benefit of caffeine 
Test R P 
KE Peak 30°/s -0.03 0.93 
KE Peak 120°/s -0.62 0.04 
KE Average 30°/s -0.014 0.967 
KE Average120°/s -0.487 0.129 
KF Peak 30°/s -0.375 0.255 
KF Peak 120°/s -0.147 0.666 
KF Average 30°/s -0.438 0.666 
KF Average120°/s -0.44 0.899 
[KE: Knee Extensor; KF: Knee Flexor; n=11 in each case] 738 
 739 
